Back to Search
Start Over
SARS-CoV-2 and neurological disorders: the revelance of biomarkers?
- Source :
- Annales de Biologie Clinique. 79:7-16
- Publication Year :
- 2021
- Publisher :
- John Libbey Eurotext, 2021.
-
Abstract
- Soon after the pandemic, numerous publications described cases of neurological disorders associated with the SARS-CoV-2 infection. The range of neurological symptoms is becoming increasingly more extensive as the pandemic progresses. However, it is not yet well established whether the manifestations are due to direct viral damage to the nervous system or indirect consequences of the infection. This review presents an inventory of the biochemical markers studied in the context of neurological disorders related to SARS-CoV-2. By reflecting various physiopathological mechanisms, these biomarkers allow both a better understanding of the pathophysiology of Covid-19 and a contribution to the diagnosis of neurologic troubles; they could participate in the prognostic evaluation of patients.
- Subjects :
- medicine.medical_specialty
2019-20 coronavirus outbreak
Coronavirus disease 2019 (COVID-19)
SARS-CoV-2
business.industry
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
COVID-19
Context (language use)
General Medicine
Prognosis
medicine.disease
Predictive Value of Tests
Acute disseminated encephalomyelitis
Pandemic
Disease Progression
medicine
Humans
Nervous System Diseases
Intensive care medicine
business
Pandemics
Neurological impairment
Biomarkers
Biochemical markers
Subjects
Details
- ISSN :
- 00033898
- Volume :
- 79
- Database :
- OpenAIRE
- Journal :
- Annales de Biologie Clinique
- Accession number :
- edsair.doi.dedup.....5465021efbcd0d6a78699f8540f715ae